Dr Robert Porter

Rob is the founder, owner and CEO of RAPIvD. He is an experienced scientist, business leader and a prominent figure in the field of rapid in vitro diagnostic technologies. He has a proven track record of founding and building specialist companies such Concepta Diagnostics and Argento Diagnostics (now AgPlus).

​

Rob is one of the world’s most experienced lateral flow professionals. He assisted with the development of the first ever home pregnancy test (Clearblue) while working for Unilever in the mid-1980s. Clearblue being a product built on the use of paired monoclonal antibodies – a technique patented by Rob’s father (Prof. Philip Porter) in 1980.

​

Rob attended the University of Wales, Swansea where he obtained a BSc and MPhil in Chemistry and a PhD in Chemistry & Immunodiagnostics. His career has included working for Unilever, the National Physical Laboratory, Concepta and Argento. He has held advisory and Board Director roles with numerous companies and was part of the UK Government’s COVID-19 response team.